J. Waisman

M. Silverstein, J. Waisman, B. Lewinsky, 1996, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Can lntraductal Breast Carcinoma Be Excised Completely by Local Excision

M. Silverstein, J. Waisman, P. Gamagami, 1994 .

Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers

J. Waisman, P. Frankel, D. Diamond, 2018, Clinical and Translational Oncology.

A phase I/II study of a HER2/neu (HER2) peptide vaccine plus concurrent trastuzumab.

J. Waisman, M. Disis, L. Salazar, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.

J. Waisman, Hailing Lu, T. Gooley, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy-Induced Activation of Hemostasis: Effect of a Low Molecular Weight Heparin (Dalteparin Sodium) on Plasma Markers of Hemostatic Activation

C. Presant, V. Israel, J. Waisman, 2002, Thrombosis and Haemostasis.

Extended Skin Island Delay of the Unipedicle TRAM Flap: Experience in 35 Patients

M. Silverstein, J. Waisman, E. Gierson, 1995, Plastic and reconstructive surgery.

Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer.

M. Silverstein, W. Ye, H. Silberman, 2002, American journal of surgery.

Breast cancer diagnosis and prognosis in women augmented with silicone gel‐filled implants

M. Silverstein, J. Waisman, P. Gamagami, 1990, Cancer.

A single institution experience with palbociclib toxicity requiring dose modifications

J. Waisman, J. Gong, M. Cho, 2017, Breast Cancer Research and Treatment.

Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer

J. Waisman, J. S. Lee, P. Frankel, 2022, Cancers.

Intraductal Breast Carcinoma—What Constitutes Adequate Treatment?

M. Silverstein, J. Waisman, B. Lewinsky, 1987 .

Prognostic classification of breast ductal carcinoma-in-situ

M. J. Silverstein, J. R. Waisman, M. Silverstein, 1995, The Lancet.

Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial

K. Allison, J. Waisman, Hailing Lu, 2017, JAMA oncology.

Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer

J. Waisman, Jian Ye, J. S. Lee, 2021, Journal for ImmunoTherapy of Cancer.

Neratinib plus fulvestrant plus trastzuzumab (N+F+T) for hormone receptor-positive (HR+), HER2-negative, HER2-mutant metastatic breast cancer (MBC): Outcomes and biomarker analysis from the SUMMIT trial.

S. Loi, M. Burkard, R. Bose, 2022, Journal of Clinical Oncology.

Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple Negative Breast Cancer.

J. Waisman, J. S. Lee, P. Frankel, 2020, The oncologist.

Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer

J. Waisman, J. Mortimer, Yinghui Huang, 2022, JCI insight.

IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer.

V. Maino, J. Waisman, Peter P. Lee, 2017, Cancer research.

Reduction mammaplasty following radiation therapy for breast cancer.

J. Waisman, B. Lewinsky, N. Handel, 1992, Plastic and reconstructive surgery.

Is It Different from Infiltrating Duct Carcinoma

J. Waisman, B. Lewinsky, P. Gamagami, 1994 .

Duct carcinoma in situ: 227 cases without microinvasion.

M. Silverstein, J. Waisman, B. Lewinsky, 1992, European journal of cancer.

Radiation therapy for intraductal carcinoma. Is it an equal alternative?

M. Silverstein, J. Waisman, B. Lewinsky, 1991, Archives of surgery.

A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab‐Paclitaxel: Melding the Fields of Geriatrics and Oncology

J. Waisman, G. Somlo, S. Blanchard, 2019, Clinical breast cancer.

A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer.

S. Highlander, J. Waisman, J. S. Lee, 2020, The oncologist.

Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer

Roger R. Wang, Lei Wang, J. Waisman, 2019, Nature Immunology.

Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.

J. Waisman, B. Nguyen, J. Link, 2007, Clinical breast cancer.

Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity

J. Waisman, M. Disis, L. Salazar, 2008, Molecular Cancer Therapeutics.

Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast.

M. Silverstein, J. Waisman, P. Gamagami, 1995, European journal of cancer.

A phase I trial of the safety and immunogenicity of a DNA-based vaccine encoding the HER2/neu (HER2) intracellular domain in subjects with HER2+ breast cancer.

J. Waisman, M. Disis, L. Salazar, 2014 .

Phase II Study of a HER-2/Neu (HER2) Intracellular Domain (ICD) Vaccine Given Concurrently with Trastuzumab in Patients with Newly Diagnosed Advanced Stage Breast Cancer.

J. Waisman, M. Disis, L. Salazar, 2009 .

Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism

Jinha M. Park, J. Waisman, P. Chu, 2014, BMC Cancer.

Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast.

S. Martino, M. Silverstein, M. Lagios, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intraductal carcinoma of the breast (208 cases): Clinical factors influencing treatment choice

M. Silverstein, J. Waisman, B. Lewinsky, 1990, Cancer.

The Fate of Breast Implants: A CriticalAnalysis of Complications and Outcomes

M. Silverstein, J. Waisman, J. A. Jensen, 1995, Plastic and reconstructive surgery.

Can intraductal breast carcinoma be excised completely by local excision? Clinical and pathologic predictors

M. Silverstein, J. Waisman, P. Gamagami, 1994, Cancer.

Abstract P5-21-08: Tolerability of the combination of lapatinib and trastuzumab in older patients with HER2 positive metastatic breast cancer

J. Waisman, G. Kimmick, H. Muss, 2018 .

Nonpalpable breast lesions: diagnosis with slightly overpenetrated screen-film mammography and hook wire-directed biopsy in 1,014 cases.

M. Silverstein, J. Waisman, P. Gamagami, 1989, Radiology.

A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico.

Arti Hurria, J. Waisman, Heeyoung Kim, 2017, Journal of geriatric oncology.

Breast Cancer After Augmentation Mammoplasty

M. Silverstein, H. Silberman, J. Waisman, 2001, Annals of Surgical Oncology.

Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer

J. Waisman, S. Mi, G. Somlo, 2017, Breast Cancer Research.

Breast cancer in women after augmentation mammoplasty.

M. Silverstein, J. Waisman, P. Gamagami, 1988, Archives of surgery.

Reasons why mastectomy patients do not have breast reconstruction.

M. Silverstein, J. Waisman, M J Silverstein, 1990, Plastic and reconstructive surgery.

Finding Earlier Nonpalpable Breast Cancers Using Hooked Wire Directed Biopsy and a Modified Overpenetrated Mammographic Technique

M. Silverstein, J. Waisman, B. Lewinsky, 1987 .

A phase I/IB study of ipatasertib in combination with carboplatin or carboplatin/paclitaxel or capecitabine and atezolizumab in patients with metastatic triple-negative breast cancer.

J. Waisman, P. Frankel, J. Mortimer, 2021 .

Abstract GS4-10: Neratinib + fulvestrant + trastuzumab for hormone receptor-positive, HER2-mutant metastatic breast cancer and neratinib + trastuzumab for triple-negative disease: Latest updates from the SUMMIT trial

H. Wildiers, A. Guerrero-Zotano, E. Yang, 2022, Cancer Research.

Building a rapid autopsy program – a step-by-step logistics guide

J. Waisman, Eliza R. Bacon, Peter P. Lee, 2020, Translational Medicine Communications.

Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer

J. Waisman, J. Mortimer, Yuan Yuan, 2023, Journal of clinical medicine.

Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer

Roger R. Wang, Lei Wang, J. Waisman, 2019, Nature Immunology.

A phase II clinical trial of pembrolizumab and selective androgen receptor modulator GTx-024 in patients with advanced androgen receptor-positive triple-negative breast cancer.

J. Waisman, P. Frankel, G. Somlo, 2019, Journal of Clinical Oncology.

Research Articles Psychosocial Outcomes of Breast Cancer Therapies: LumpectomyVersus Mastectomy

J. Waisman, J. Landsverk, D. Wellisch, 1989 .

Axillary lymphadenectomy for intraductal carcinoma of the breast.

M. Silverstein, J. Waisman, P. Gamagami, 1991, Surgery, gynecology & obstetrics.

A phase I study of a DNA plasmid based vaccine encoding the HER2/neu (HER2) intracellular domain (ICD) in subjects with HER2+ breast cancer.

J. Waisman, M. Disis, L. Salazar, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer

J. Waisman, S. Mi, G. Somlo, 2017, Breast Cancer Research.

Phase I study of intratumoral administration of CF33-HNIS-antiPDL1 in patients with metastatic triple negative breast cancer.

J. Waisman, S. Chaurasiya, J. Mortimer, 2022, Journal of Clinical Oncology.

Phase 2 prospective open label study of neoadjuvant nab‐paclitaxel, trastuzumab, and pertuzumab in patients with HER2‐positive primary breast cancer

J. Waisman, P. Frankel, G. Somlo, 2022, Cancer.

Effects of breast cancer treatment on the hormonal and cognitive consequences of acute stress

Joseph M. Andreano, L. Cahill, J. Waisman, 2012, Psycho-oncology.

Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer

A. Saykin, A. Holodny, J. Waisman, 2018, Breast Cancer Research and Treatment.

Project connect online: randomized trial of an internet-based program to chronicle the cancer experience and facilitate communication.

Catherine M Crespi, J. Waisman, A. Stanton, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract PD1-05: Latest findings from the breast cancer cohort in SUMMIT - a phase 2 ‘basket’ trial of neratinib + trastuzumab + fulvestrant forHER2-mutant, hormone receptor-positive, metastatic breast cancer

S. Loi, M. Burkard, H. Wildiers, 2021 .

Abstract P3-07-27: Distinct biomarker features in triple-negative breast cancer metastases to the brain, liver and bone

J. Waisman, Z. Gatalica, J. Xiu, 2016 .

Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study

A. Saykin, E. Haacke, A. Holodny, 2018, Breast Cancer Research.

Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer

J. Waisman, J. S. Lee, P. Frankel, 2023, Cancer Immunology, Immunotherapy.

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

S. Loi, M. Burkard, R. Bose, 2023, Annals of Oncology.

Thrombopoietin Receptor Agonists for Thrombocytopenia Secondary to HER2-Targeted Antibody Drug Conjugates

J. Waisman, J. Mortimer, Yuan Yuan, 2023, The oncologist.

HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia

J. Waisman, J. Mortimer, Yuan Yuan, 2023, Breast Cancer.

Effects of breast cancer treatment on the hormonal and cognitive consequences of acute stress

Joseph M. Andreano, L. Cahill, J. Waisman, 2012, Psycho-oncology.

A phase 1 study of p53MVA vaccine in combination with pembrolizumab.

J. Waisman, P. Frankel, D. Diamond, 2018 .